… The first study to assess effects of low-dose spironolactone (25 … active treatments, doxazosin
(−4.03 mm Hg) and bisoprolol (−… of BP after treatment with spironolactone versus doxazosin …

… spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment
… Specifically, the addition of “low-dose spironolactone to existing treatment, or the addition …

… Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment
for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trial. …

… in patients with RHTN undergoing treatment with SNB or DRASB… plus bisoprolol in patients
with RHTN and to assess the side … We selected a low dose of spironolactone (25 mg/day), as …

… Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment
for drug-… Patiromer versus placebo to enable spironolactone use in patients with resistant …

… , spironolactone in a dose of 25–50 mg was compared to bisoprolol (5–10 mg), doxazosin
(5–10 mg) or placebo.[35] … [7] To assess their efficacy, the resistant HT optimal treatment study …

… results of our main analysis with spironolactone as the most effective treatment, while no …
Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment …

… to either spironolactone (25–50 mg/day) or usual care alone for a … assess whether the
spironolactone effect on variables of interest previously found to be modified by the treatment …

… Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment
for drug-… Clinical e cacy of spironolactone for resistant hypertension: a meta-analysis from …

… (Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment
… hypertension) was a multiway cross-over trial which demonstrated that spironolactone is …